>

>

AstraZeneca sees higher 2022 sales, but COVID boost waning

AstraZeneca sees higher 2022 sales, but COVID boost waning

AstraZeneca sees higher 2022 sales, but COVID boost waning

By Excelsio Media on febrero 10, 2022 Also in AstraZeneca, economy

AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade, but warned that the boost from COVID-19 products would fall.

Comentarios

Comentarios de Facebook

Suscribirse a: Enviar comentarios (Atom)